Uterine Manipulation Devices Market Size, Share & Trends Analysis Report By Application (Total Laparoscopy Hysterectomy, Laparoscopic Supracervical Hysterectomy), By End-use (Hospitals, ASCs)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2021-2027

The global Uterine Manipulation Devices market gathered revenue around USD 238.85 Million in 2020 and market is set to grow USD 350.75 Million by the end of 2027 and is estimated to expand at a modest CAGR of 4.65% during the prediction period 2021 to 2027.

Uterine Manipulation Devices Market Size 2020 to 2027

Growth Factors:

A surge in the prevalence of gynecological diseases, coupled with the rising preference for minimally invasive surgical procedures, is a key driving factor for the market.

The increasing prevalence of various gynecological disorders and the growing adoption of uterine manipulation devices owing to their ease of use and convenience are among factors expected to boost the market growth during the forecast period. The prevalence of UF tumors increases as women grow older and it is prevalent in over 30% of women aged between 40 and 60. UF usually develops in women in their late 40s and early 50s, though in some women it may occur at a younger age. Thus, the increasing number of women suffering from UF has led to a rise in the number of hysterectomy procedures, leading to significant demand for uterine manipulation devices.

Moreover, several key players are investing in R&D for the launch of innovative minimally and noninvasive surgical instruments. Currently, various advanced manipulators are available in the market. For instance, during colpotomy procedure, usually manipulators with a cup to fit over the cervix are preferred. These include RUMI in combination with KOH cups (by CooperSurgical, Inc.) and VCare (by CONMED Corporation). Therefore, various advantages offered by these devices are cumulatively responsible for boosting the demand for minimally invasive procedures, thereby propelling the market growth.

The high prevalence of disorders related to the female reproductive system in developed and developing countries has driven the launch of technologically advanced products in the market. Some of the key players operating in this market are CooperSurgical, Inc.; Stryker Corporation; KARL STORZ GmbH; CONMED Corporation; and Ethicon, Inc. Technological advancements such as the introduction of laparoscopic or robotic-assisted hysterectomy procedures have led to the adoption of incision-less surgery with no or minimal side effects. As compared to open abdominal hysterectomy, robotic-assisted hysterectomy provides advantages such as less blood loss, fewer complications, and faster return to normal activities. Thus, the use of robots, owing to their several advantages over conventional laparoscopy (open surgery), has been widely accepted and incorporated in the field of reproductive surgery. This is expected to be a high-impact rendering driver of the market.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Uterine Manipulation Devices market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Uterine Manipulation Devices market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

Report Coverage

Report Scope Details
Market Size USD 350.75 Million by 2027
Growth Rate CAGR of 4.65% From 2021 to 2027
Base Year 2020
Forecast Period 2021 to 2027
Historic Data 2017 to 2020
Report coverage Growth Factors, Revenue Status, Competitive Landscape,  and Future Trends
Segments Covered Application, end-use And Region
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Conkin Surgical Instruments Ltd.; Johnson and Johnson; CooperSurgical, Inc.; B. Braun Medical Ltd.; KARL STORZ GmbH & Co. KG; CONMED Corporation; RUDOLF Medical GmbH + Co. KG; LiNA Medical ApS; Richard Wolf GmbH; Utah Medical Products, Inc.; Purple Surgical; Clinical Innovations, LLC; Bissinger Medizintechnik; The O.R. Company (Symmetry Surgical Inc.); LSI Solutions, Inc..

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Uterine Manipulation Devices market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

Regional analysis:

North America dominated the market with a share of 36.10% in 2020 and is expected to witness considerable growth over the forecast period. This is owing to the increasing number of gynecology-related surgical procedures/hospital visits, the presence of well-established healthcare infrastructure, favorable reimbursement policies, and supportive regulatory reforms in the healthcare sector. According to CMS, healthcare spending in the U.S. increased by 4.1% and reached USD 3.8 trillion in 2019, accounting for approximately 17.2% of GDP. The national health spending is expected to grow at an annual rate of 5.0% from 2019 to 2027, to reach USD 6.0 trillion by the year 2027. The ease of access to healthcare technologies and the presence of strong distribution channels are also driving the adoption of uterine manipulation devices in the region.

The Asia Pacific market is anticipated to exhibit lucrative growth during the forecast period. The presence of a large patient pool and the growing need for technologically advanced and cost-effective healthcare solutions are among the factors expected to present significant growth opportunities for the market. Moreover, an increase in the number of clinical trials and high R&D investments by global market players to enter untapped markets in the Asia Pacific region owing to low-cost services are high-impact rendering drivers of the market. In addition, an increase in the number of hospitalizations and rapid advancements in the clinical development framework of developing economies are aiding market growth in this region.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

  • Company Overview
  • Company Market Share/Positioning Analysis
  • Product Offerings
  • Financial Performance
  • Recent Initiatives
  • Key Strategies Adopted by Players
  • Vendor Landscape
  • List of Suppliers
  • List of Buyers

Some of the prominent players in the Uterine Manipulation Devices Market include: Conkin Surgical Instruments Ltd.; Johnson and Johnson; CooperSurgical, Inc.; B. Braun Medical Ltd.; KARL STORZ GmbH & Co. KG; CONMED Corporation; RUDOLF Medical GmbH + Co. KG; LiNA Medical ApS; Richard Wolf GmbH; Utah Medical Products, Inc.; Purple Surgical; Clinical Innovations, LLC; Bissinger Medizintechnik; The O.R. Company (Symmetry Surgical Inc.); LSI Solutions, Inc.

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

  • By Application
    • Total Laparoscopy Hysterectomy (TLH)
    • Laparoscopic Supracervical Hysterectomy (LSH)
    • Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
    • Sacrocolpopexy
    • Other Applications
  • By End-use
    • Hospitals
    • Clinics
    • Ambulatory Surgery Centers (ASCs)

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Highlights of the Report:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market

Research Methodology

In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Uterine Manipulation Devices market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the Uterine Manipulation Devices market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Uterine Manipulation Devices markets more accurate and reliable.

Secondary Research

It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
  • In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

Industry participants involved in this research study include:

  • CEOs, VPs, market intelligence managers
  • Procuring and national sales managers technical personnel, distributors and resellers
  • Research analysts and key opinion leaders from various domains

Key Points Covered in Uterine Manipulation Devices market Study:

  • Growth of Uterine Manipulation Devices in 2021
  • Market Estimates and Forecasts (2017-2027)
  •  Brand Share and Market Share Analysis
  •  Key Drivers and Restraints Shaping Market Growth
  •  Segment-wise, Country-wise, and Region-wise Analysis
  •  Competition Mapping and Benchmarking
  •  Recommendation on Key Winning Strategies
  •  COVID-19 Impact on Demand for Uterine Manipulation Devices and How to Navigate
  •  Key Product Innovations and Regulatory Climate
  •  Uterine Manipulation Devices Consumption Analysis
  •  Uterine Manipulation Deices Production Analysis
  •  Uterine Manipulation Devices and Management

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Uterine Manipulation Devices Market, By Application

7.1.  Uterine Manipulation Devices Market, by Application, 2021-2027

7.1.1.     Total Laparoscopy Hysterectomy (TLH)

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Laparoscopic Supracervical Hysterectomy (LSH)

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Laparoscopically Assisted Vaginal Hysterectomy (LAVH)

7.1.3.1.          Market Revenue and Forecast (2016-2027)

7.1.4.     Sacrocolpopexy

7.1.4.1.          Market Revenue and Forecast (2016-2027)

7.1.5.     Other Applications

7.1.5.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Uterine Manipulation Devices Market, By End-use

8.1.  Uterine Manipulation Devices Market, By End-use, 2021-2027

8.1.1.     Hospitals

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Clinics

8.1.2.1.          Market Revenue and Forecast (2016-2027)

8.1.3.     Ambulatory Surgery Centers (ASCs)

8.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Uterine Manipulation Devices Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.     Market Revenue and Forecast, by Application (2016-2027)

9.1.2.     Market Revenue and Forecast, By End-use (2016-2027)

9.1.3.     U.S.

9.1.3.1.          Market Revenue and Forecast, by Application (2016-2027)

9.1.3.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.1.4.     Rest of North America

9.1.4.1.          Market Revenue and Forecast, by Application (2016-2027)

9.1.4.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.2.  Europe

9.2.1.     Market Revenue and Forecast, by Application (2016-2027)

9.2.2.     Market Revenue and Forecast, By End-use (2016-2027)

9.2.3.     UK

9.2.3.1.          Market Revenue and Forecast, by Application (2016-2027)

9.2.3.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.2.4.     Germany

9.2.4.1.          Market Revenue and Forecast, by Application (2016-2027)

9.2.4.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.2.5.     France

9.2.5.1.          Market Revenue and Forecast, by Application (2016-2027)

9.2.5.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.2.6.     Rest of Europe

9.2.6.1.          Market Revenue and Forecast, by Application (2016-2027)

9.2.6.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.3.  APAC

9.3.1.     Market Revenue and Forecast, by Application (2016-2027)

9.3.2.     Market Revenue and Forecast, By End-use (2016-2027)

9.3.3.     India

9.3.3.1.          Market Revenue and Forecast, by Application (2016-2027)

9.3.3.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.3.4.     China

9.3.4.1.          Market Revenue and Forecast, by Application (2016-2027)

9.3.4.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.3.5.     Japan

9.3.5.1.          Market Revenue and Forecast, by Application (2016-2027)

9.3.5.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.3.6.     Rest of APAC

9.3.6.1.          Market Revenue and Forecast, by Application (2016-2027)

9.3.6.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.4.  MEA

9.4.1.     Market Revenue and Forecast, by Application (2016-2027)

9.4.2.     Market Revenue and Forecast, By End-use (2016-2027)

9.4.3.     GCC

9.4.3.1.          Market Revenue and Forecast, by Application (2016-2027)

9.4.3.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.4.4.     North Africa

9.4.4.1.          Market Revenue and Forecast, by Application (2016-2027)

9.4.4.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.4.5.     South Africa

9.4.5.1.          Market Revenue and Forecast, by Application (2016-2027)

9.4.5.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.4.6.     Rest of MEA

9.4.6.1.          Market Revenue and Forecast, by Application (2016-2027)

9.4.6.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.5.  Latin America

9.5.1.     Market Revenue and Forecast, by Application (2016-2027)

9.5.2.     Market Revenue and Forecast, By End-use (2016-2027)

9.5.3.     Brazil

9.5.3.1.          Market Revenue and Forecast, by Application (2016-2027)

9.5.3.2.          Market Revenue and Forecast, By End-use (2016-2027)

9.5.4.     Rest of LATAM

9.5.4.1.          Market Revenue and Forecast, by Application (2016-2027)

9.5.4.2.          Market Revenue and Forecast, By End-use (2016-2027)

Chapter 10.   Company Profiles

10.1.                 Conkin Surgical Instruments Ltd.

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.                 Johnson and Johnson

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.                  CooperSurgical, Inc.;

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.                 B. Braun Medical Ltd

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.                 KARL STORZ GmbH & Co. KG

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.                 CONMED Corporation

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.                  RUDOLF Medical GmbH + Co. KG

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.                 LiNA Medical ApS

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.                 Richard Wolf GmbH

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.              Utah Medical Products, Inc.

10.10.1.                   Company Overview

10.10.2.                   Product Offerings

10.10.3.                   Financial Performance

10.10.4.                   Recent Initiatives

Chapter 11.   Research Methodology

11.1.                 Primary Research

11.2.                 Secondary Research

11.3.                 Assumptions

Chapter 12.   Appendix

12.1.                 About Us

12.2.                 Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers